Literature DB >> 20673981

Effective treatment of therapy-resistant chronic spontaneous urticaria with omalizumab.

Markus Magerl, Petra Staubach, Sabine Altrichter, Elena Ardelean, Karoline Krause, Martin Metz, Karsten Weller, Marcus Maurer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20673981     DOI： 10.1016/j.jaci.2010.05.047

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  14 in total

1.  The role of autoimmune testing in chronic idiopathic urticaria.

Authors:  Ravi K Viswanathan; Mark J Biagtan; Sameer K Mathur
Journal:  Ann Allergy Asthma Immunol       Date:  2012-03-21       Impact factor: 6.347

2.  Retrospective analysis of the efficacy of omalizumab in chronic refractory urticaria.

Authors:  Ravi K Viswanathan; Mark H Moss; Sameer K Mathur
Journal:  Allergy Asthma Proc       Date:  2013 Sep-Oct       Impact factor: 2.587

Review 3.  Benefits and Harms of Omalizumab Treatment in Adolescent and Adult Patients With Chronic Idiopathic (Spontaneous) Urticaria: A Meta-analysis of "Real-world" Evidence.

Authors:  Michael D Tharp; Jonathan A Bernstein; Abhishek Kavati; Benjamin Ortiz; Karen MacDonald; Kris Denhaerynck; Ivo Abraham; Christopher S Lee
Journal:  JAMA Dermatol       Date:  2019-01-01       Impact factor: 10.282

Review 4.  Biologic modulators in allergic and autoinflammatory diseases.

Authors:  Lori Broderick; Louanne M Tourangeau; Arthur Kavanaugh; Stephen I Wasserman
Journal:  Curr Opin Allergy Clin Immunol       Date:  2011-08

Review 5.  Basophils and allergic inflammation.

Authors:  Mark C Siracusa; Brian S Kim; Jonathan M Spergel; David Artis
Journal:  J Allergy Clin Immunol       Date:  2013-10       Impact factor: 10.793

6.  [Therapeutic alternatives for antihistamine-refractory urticaria].

Authors:  M Maurer; S Altrichter; E Ardelean; K Krause; M Magerl; M Metz; F Siebenhaar; K Weller; T Zuberbier
Journal:  Hautarzt       Date:  2010-09       Impact factor: 0.751

Review 7.  Omalizumab: Anti-IgE therapy in allergy.

Authors:  Matthias Volkmar Kopp
Journal:  Curr Allergy Asthma Rep       Date:  2011-04       Impact factor: 4.806

8.  T cell activity in successful treatment of chronic urticaria with omalizumab.

Authors:  Inmaculada Sánchez-Machín; Javier Iglesias-Souto; Andrés Franco; Yvelise Barrios; Ruperto Gonzalez; Víctor Matheu
Journal:  Clin Mol Allergy       Date:  2011-07-26

9.  Omalizumab for chronic urticaria: a case series and overview of the literature.

Authors:  Ilya Ivyanskiy; Carsten Sand; Simon Francis Thomsen
Journal:  Case Rep Dermatol       Date:  2012-01-30

Review 10.  Profile of omalizumab in the treatment of chronic spontaneous urticaria.

Authors:  Moises Labrador-Horrillo; Marta Ferrer
Journal:  Drug Des Devel Ther       Date:  2015-08-25       Impact factor: 4.162
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.